Question 13447 — maternity health insurance

Summary

Mr. Joël Aviragnet draws the attention of the Minister of Solidarity and Health to the consequences of the delisting of Alzheimer's medications. Indeed, since August 1, 2018, medications prescribed for Alzheimer's disease are no longer covered by health insurance. This decision arouses strong emotion and major incomprehension among patients and their loved ones. Indeed, if it is impossible to fight the disease Directly, however, these medications make it possible to combat certain effects and behaviors. This is no small thing for the loved ones of patients who live daily with a person who changes and moves away from the person they knew. Since the official announcement by his ministry, millions of families affected by the disease have mobilized to denounce this measure. The largest learned societies, and France-Alzheimer and diseases related companies, even filed an appeal before the Council of State. France has 1.1 million people living with this disease and this figure could rise to 2 million in 2040. The management of this pathology is therefore a public health and solidarity issue. He therefore wishes to know what the Government intends to do in order to find real solutions to effectively help patients and their families.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.